As the country’s first LC-MAX® unit, this deployment positions HPCL at the forefront of technological and operational innovation. By integrating advanced intelligence, we are setting a new benchmark” ...

Athira Pharma has joined an attempt to rescue an asset abandoned by Pfizer. The biotech has secured near-global rights to a phase 3 breast cancer prospect in a deal with Sermonix Pharmaceuticals.

This is read by an automated voice. Please report any issues or inconsistencies here. The EU indefinitely froze roughly $247 billion in Russian assets Friday, blocking Hungary and Slovakia from ...

Scaling Up: CEO António Caçorino thinks APEX will be in “a beautiful sweet spot” acquiring minority stakes in small and mid-size targets, mostly in Europe—an area of the sports world that has largely ...

As the world becomes increasingly digitized, schools face a responsibility to keep up. Some have incorporated RFID, IoT and artificial intelligence (AI) technologies to enhance organization and ...

The MQ771-GL supports 3GPP Release 14 Cat.M1 and NB-IoT standards and is compatible with mainstream frequency bands worldwide, making it ideal for LPWA network deployments across North America, Europe ...

Scientists used tiny new sensors to follow the insects on journeys that take thousands of miles to their winter colonies in Mexico. Scientists used tiny new sensors to follow the insects on journeys ...

The U.S. rail freight system is a backbone of national commerce, moving over 40% of long-distance freight volumes across a network of nearly 140,000 miles. As global supply chains face mounting ...

ZURICH / LUXEMBOURG, ZURICH, SWITZERLAND, November 11, 2025 /EINPresswire.com/ -- BrickMark X AG, a leading digital asset platform provider specialized in structuring ...

Yacktman Asset Management's Q3 2025 13F portfolio value declined to $7.26B, with 70 holdings and ~9% cash. Top five positions—Canadian Natural Resources, Microsoft, Fox Corp., Charles Schwab, Procter ...

AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ...